Clinical Trial Update: Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposome-encapsulated doxorubicin citrate with or without gemcitabine hydrochloride in patients with ovarian epithelial cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Liposome-encapsulated doxorubicin citrate (doxorubicin citrate liposome)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN